Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
SMMT compared with ACAD: revenue, margins and what each company keeps, and the suppliers and customers both name
SMMT
Summit Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
ACAD
Acadia Pharmaceuticals Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
SMMT
Summit Therapeutics Inc.
vs
ACAD
Acadia Pharmaceuticals Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
SMMT
Summit Therapeutics Inc.
Change
16.01
· pre 16.03
Mkt cap
$12.8B
Revenue
—
Revenue
—
ACAD
Acadia Pharmaceuticals Inc
Change
20.59
· pre 20.42
Pre-market
Sep 2 '83
Mkt cap
$3.5B
Revenue
$308M
Q2 FY26
Revenue
$1.1B
FY25
vs
Compare
Pre-market
Sep 2 '83
SMMT
Summit Therapeutics Inc.
vs
ACAD
Acadia Pharmaceuticals Inc
16.01
pre 16.03
Price
20.59
pre 20.42
$12.8B
Mkt cap
$3.5B
—
Revenue
$308M
Q2 FY26
—
Revenue
$1.1B
FY25
Change
Change
SMMT
16.01
vs
ACAD
20.59
Pre-market
Sep 2 '83
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
SMMT: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only SMMT
4
—
Akeso, Inc. and its affiliates (collectively, "Akeso")
unlisted
supplier
—
Akeso
unlisted
supplier
—
Gortec
unlisted
supplier
—
Dr. Zanganeh
unlisted
customer
Shared
0
No shared counterparties.
Only ACAD
4
STOK
Stoke Therapeutics
supplier
—
Neuren
unlisted
supplier
—
Single wholesale distributor
unlisted
customer
—
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Third party distributors
unlisted
customer
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
SMMT, solid
ACAD, dashed